<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nutra Pharma Corp. (NPC) :: NPC Blog</title>
	<atom:link href="http://www.nutrapharma.com/blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.nutrapharma.com/blog</link>
	<description>The corporate blog of Nutra Pharma Corporation</description>
	<lastBuildDate>Tue, 20 Dec 2011 14:55:23 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Nutra Pharma Letter to Shareholders</title>
		<link>http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/</link>
		<comments>http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 14:55:23 +0000</pubDate>
		<dc:creator>Rik J. Deitsch</dc:creator>
				<category><![CDATA[In the News]]></category>
		<category><![CDATA[Investor Relations]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Nutra Pharma]]></category>
		<category><![CDATA[ReceptoPharm]]></category>
		<category><![CDATA[Rik Deitsch]]></category>

		<guid isPermaLink="false">http://www.nutrapharma.com/blog/?p=987</guid>
		<description><![CDATA[Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company. December 19, 2011 &#8212; Coral Springs, Florida &#8212; Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, [...]]]></description>
			<content:encoded><![CDATA[<p><em>Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company.</em></p>
<p><em> </em></p>
<p><em>December 19, 2011</em> &#8212; <em>Coral Springs, Florida</em> &#8212; Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the Company&#8217;s Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company&#8217;s website.</p>
<p>“We have been very busy here at Nutra Pharma,” explained Rik J Deitsch, Chairman and CEO of <a href="../../../../../../">Nutra Pharma Corporation</a>. “I wanted to take this opportunity to outline the progress that we&#8217;ve made and the timeline for our future efforts moving into 2012 and beyond,” he concluded.</p>
<p>Nutra Pharma currently produces three drugs for the treatment of pain: Cobroxin<sup>®</sup>, an over-the-counter pain reliever designed to treat moderate to severe (Stage 2) chronic pain; as well as <a href="http://www.nyloxin.com/">Nyloxin</a>™ and Nyloxin™ Extra Strength, stronger versions of Cobroxin<sup>®</sup>. These products are currently available in the United States as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress.<a title="4Q11 Shareholder Letter" href="http://www.nutrapharma.com/newsroom/display.php?newsid=195" target="_blank"></a></p>
<p><a title="4Q11_Shareholder_letter.pdf" href="http://www.nutrapharma.com/4Q11_shareholder_letter.pdf" target="_blank">Click here to download the letter</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain</title>
		<link>http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/</link>
		<comments>http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 14:31:48 +0000</pubDate>
		<dc:creator>Corporate Communications</dc:creator>
				<category><![CDATA[Chronic Pain]]></category>
		<category><![CDATA[Nutra Pharma]]></category>
		<category><![CDATA[ReceptoPharm]]></category>
		<category><![CDATA[Rik Deitsch]]></category>
		<category><![CDATA[Alpha-Cobratoxin]]></category>
		<category><![CDATA[cobra venom]]></category>
		<category><![CDATA[multiple sclerosis]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[pain management]]></category>

		<guid isPermaLink="false">http://www.nutrapharma.com/blog/?p=980</guid>
		<description><![CDATA[Nutra Pharma announces the publication of their study outlining the mechanism of action of their pain drugs to be published in the journal Neuropharmacology. November 30, 2011 &#8212; Coral Springs, Florida &#8212; Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and [...]]]></description>
			<content:encoded><![CDATA[<p><em>Nutra Pharma announces the publication of their study outlining the mechanism of action of their pain drugs to be published in the journal Neuropharmacology.</em></p>
<p><em> </em></p>
<p><em>November 30, 2011</em> &#8212; <em>Coral Springs, Florida</em> &#8212; Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal <a href="http://www.journals.elsevier.com/neuropharmacology/">Neuropharmacology</a> will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain. <a title="Alpha-Cobratoxin in the Treatment of Pain" href="http://www.nutrapharma.com/newsroom/display.php?newsid=194" target="_blank">Read on…</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Incredible Offer on Cobroxin!</title>
		<link>http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/</link>
		<comments>http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/#comments</comments>
		<pubDate>Thu, 17 Nov 2011 19:41:15 +0000</pubDate>
		<dc:creator>Corporate Communications</dc:creator>
				<category><![CDATA[Chronic Pain]]></category>
		<category><![CDATA[Cobra Venom]]></category>
		<category><![CDATA[Cobroxin]]></category>

		<guid isPermaLink="false">http://www.nutrapharma.com/blog/?p=954</guid>
		<description><![CDATA[SAVE! on the first over-the-counter pain reliever clinically proven to treat various levels of chronic pain. Specially formulated for arthritis, lower back pain, shoulder pain,migraines, and neuralgia. Now Only $10.99 Regular Price $25.99 And, when you purchase the Cobroxin Gel, you will get the Oral Spray for free, that’s a total savings of $21.00! Just [...]]]></description>
			<content:encoded><![CDATA[<h2>SAVE!</h2>
<h2><a href="http://www.nutrapharma.com/blog/wp-content/uploads/2011/11/cob-gelad21.gif"><img title="cob-gelad2" src="http://www.nutrapharma.com/blog/wp-content/uploads/2011/11/cob-gelad21-300x160.gif" alt="" width="300" height="160" /></a></h2>
<h2>on the first over-the-counter pain reliever clinically proven to treat various levels of chronic pain.</h2>
<p><strong>Specially formulated for </strong><strong>arthritis, </strong><strong> lower back pain, shoulder pain,migraines, and neuralgia.</strong></p>
<h1>Now Only $10.99</h1>
<p><strong>Regular Price $25.99</strong><br />
And, when you purchase the Cobroxin Gel, you will get the Oral Spray for free, that’s a total savings of $21.00!</p>
<p><strong>Just use Coupon Code: NP11 at checkout</strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Plus, take advantage of Free Ground Shipping (in the USA) until December 31, 2011.</strong></p>
<p><a title="Cobroxin Promo" href="http://www.nyloxin.com/shop/Cobroxin-Gel-Spray-Promo.html"><strong>BUY NOW</strong></a></p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Season&#8217;s Greeting with Free Shipping on Nyloxin</title>
		<link>http://www.nutrapharma.com/blog/2011/11/16/945/</link>
		<comments>http://www.nutrapharma.com/blog/2011/11/16/945/#comments</comments>
		<pubDate>Wed, 16 Nov 2011 17:12:14 +0000</pubDate>
		<dc:creator>Corporate Communications</dc:creator>
				<category><![CDATA[Nyloxin]]></category>

		<guid isPermaLink="false">http://www.nutrapharma.com/blog/?p=945</guid>
		<description><![CDATA[Your friends at Nutra Pharma Corp. wish you a Pain-Free Holiday Season with FREE Ground Shipping on any purchase on Nyloxin.com over $40.00 www.nyloxin.com Free ground shipping within the USA expires December 31, 2011. &#160;]]></description>
			<content:encoded><![CDATA[<div style="text-align: left;">
<h1 style="text-align: center;"><span style="text-align: center; line-height: 28px; color: #888888;"> </span></h1>
<h1><span style="text-align: center; line-height: 28px; color: #888888;">Your friends at Nutra Pharma Corp. wish you a Pain-Free Holiday Season with FREE Ground Shipping on any purchase on Nyloxin.com over $40.00</span></h1>
<p><a title="Season's Greetings from Nyloxin" href="http://www.nyloxin.com/shop/Shop-Online.html" target="_blank">www.nyloxin.com</a><br />
Free ground shipping within the USA expires December 31, 2011.</p>
<p>&nbsp;</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.nutrapharma.com/blog/2011/11/16/945/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

